Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Journal of the National Cancer Institute

• Publication date

  1984-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/JNCI/72.4.955PMID 6200641
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Isolation and purification of deoxyribonucleic acid from mycobacteria.

  2009cited by this paper
• Effect of bestatin on mouse immune system and experimental murine tumors.

  1980cited by this paper
• Chemical and biological properties of hot water extract from delipidated cells of Mycobacterium bovis strain BCG.

  1976cited by this paper
• Mycobacterial ribonucleic acid: comparison with mycobacterial cell wall fractions for regression of murine tumor growth

  1976cited by this paper
• Mycobacterial RNA. A comparison with intact mycobacteria for suppression of murine tumor growth.

  1976cited by this paper
• Application of nitrous acid deamination of hexosamines to the simultaneous GLC determination of neutral and amino sugars in glycoproteins.

  1975cited by this paper
• Biologically active components from mycobacterial cell walls. I. Isolation and composition of cell wall skeleton and component P3.

  1974cited by this paper
• Immunotherapy of cancer: regression of established intradermal tumors after intralesional injection of mycobacterial cell walls attached to oil droplets.

  1974cited by this paper
• Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells.

  1974cited by this paper
• Purification of Mycobacterial Deoxyribonucleic Acid

  1972cited by this paper
• Isolation and properties of a macromolecular, water-soluble, immuno-adjuvant fraction from the cell wall of Mycobacterium smegmatis.

  1972cited by this paper
• Water-soluble and lipid-free fraction from BCG with adjuvant and antitumour activity.

  1972cited by this paper
• Endotoxin and double stranded RNA render macrophages cytotoxic.

  1971cited by this paper
• Suppression of tumor growth at the site of infection with living Bacillus Calmette-Guérin.

  1971cited by this paper
• Isolation and Analysis of the Nucleic Acids and Polysaccharides from Clostridium welchii

  1970cited by this paper
• Inhibition of neoplastic cell growth by autogenous DNA.

  1968cited by this paper
• The specificity of inhibition of tumor cell viability by DNA.

  1967cited by this paper
• Inhibition of L1210 Tumor Growth by Thymus DNA

  1965cited by this paper
• STUDIES ON THE HETEROLOGOUS IMMUNOGENICITY OF A METHANOL-INSOLUBLE FRACTION OF ATTENUATED TUBERCLE BACILLI (BCG)

  1964cited by this paper
• Use of Alkyltrimethylammonium Bromides for the Isolation of Ribo- and Deoxribo-nucleic Acids

  1963cited by this paper
• A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

  1956cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper
• THE RÔLE OF THE "WAX" OF THE TUBERCLE BACILLUS IN ESTABLISHING DELAYED HYPERSENSITIVITY

  1949cited by this paper
• Phosphorus compounds in animal tissues; a comparison of methods for the estimation of nucleic acids.

  1946cited by this paper

• Cytosolic nucleic acid sensing as driver of critical illness: mechanisms and advances in therapy

  2025cites this paper
• Interconnection of the Gut-Skin Axis in NC/Nga Mouse with Atopic Dermatitis: Effects of the Three Types of Bifidobacterium bifidum CBT-BF3 (Probiotics, Postbiotics, and Cytosine-Phosphate-Guanine Oligodeoxynucleotide) on T Cell Differentiation and Gut Microbiota

  2024cites this paper
• Exploiting bacterial-origin immunostimulants for improved vaccination and immunotherapy: current insights and future directions

  2024cites this paper
• Considerations for Creating the Next Generation of RNA Therapeutics: Oligonucleotide Chemistry and Innate Immune Responses to Nucleic Acids

  2024cites this paper
• Recent Insights into the Molecular Mechanisms of the Toll-like Receptor Response to Influenza Virus Infection

  2024cites this paper
• CpG-Containing Oligodeoxynucleotides and Freund Adjuvant in Combination with Alum Augment the Production of Monoclonal Antibodies Against Recombinant HBsAg

  2022cites this paper
• A first-in-human phase 1 study of cavrotolimod, a TLR9 agonist spherical nucleic acid, in healthy participants: Evidence of immune activation

  2022cites this paper
• Immune Stimulation by Oligonucleotides

  2021cites this paper
• ICAM-1-Induktion durch CpG-ODN im murinen, orthotopen UCC-Modell – Immunhistochemische Analyse der lokalen Immunantwort auf immunstimulatorische DNA-Sequenzen

  2021cites this paper
• The role of bacterial DNA containing CpG motifs in diseases

  2021cites this paper
• The Evolution of Antisense Oligonucleotide Chemistry—A Personal Journey

  2021cites this paper
• RNA/DNA sensing in SLE—Toll-like receptors and beyond

  2021cites this paper
• One Hundred Ten Years of Allergen Immunotherapy: A Broad Look Into the Future.

  2021cites this paper
• The next generation of HCV vaccines: a focus on novel adjuvant development

  2021cites this paper
• Overview of the microbiota in the gut-liver axis in viral B and C hepatitis

  2021cites this paper
• Progress in the Use of Antisense Oligonucleotides for Vaccine Improvement

  2020cites this paper
• New insights into the evasion of host innate immunity by Mycobacterium tuberculosis

  2020cites this paper
• The Role of Extracellular DNA and Histones in Ischaemia-Reperfusion Injury of the Myocardium

  2020cites this paper
• Nucleic Acid Immunotherapeutics for Cancer.

  2020cites this paper
• N6-methylated adenine on the target sites of mamA from Mycobacterium bovis BCG enhances macrophage activation by CpG DNA in mice.

  2020cites this paper
• Evaluation of CpG DNA for Increasing Immune Gene Expression in Grouper (Epinephelus fuscoguttatus)

  2020influential citation
• Toll-Like Receptor 21 of Chicken and Duck Recognize a Broad Array of Immunostimulatory CpG-oligodeoxynucleotide Sequences

  2020cites this paper
• Hydrophobic Interaction: A Promising Driving Force for the Biomedical Applications of Nucleic Acids

  2020cites this paper
• Adjuvant Effect of Toll-Like Receptor 9 Activation on Cancer Immunotherapy Using Checkpoint Blockade

  2020cites this paper
• Historical Perspectives

  2019cites this paper
• Production of lentiviral vectors using novel, enzymatically produced, linear DNA

  2019cites this paper
• Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21

  2019cites this paper
• Macrophage Phosphoproteome Analysis Reveals MINCLE-dependent and -independent Mycobacterial Cord Factor Signaling*

  2019cites this paper
• Synthetic CpG oligonucleotides as potential modulators of neutrophil survival in PAMP‐associated inhibition of apoptosis

  2019cites this paper
• Unmethylated CpG motif-containing genomic DNA fragment of Bacillus calmette-guerin promotes macrophage functions through TLR9-mediated activation of NF-κB and MAPKs signaling pathways

  2019cites this paper
• Lactobacillus rhamnosus GG components, SLP, gDNA and CpG, exert protective effects on mouse macrophages upon lipopolysaccharide challenge

  2019cites this paper
• The revival of CpG oligonucleotide-based cancer immunotherapies

  2018cites this paper
• In vitro induction of T regulatory cells by a methylated CpG DNA sequence in humans: Potential therapeutic applications in allergic and autoimmune diseases.

  2018influential citation
• IMMUNOPROTECTIVE MECHANISMS ASSOCIATED WITH IN OVO DELIVERY OF OLIGODEOXYNUCLEOTIDES CONTAINING CpG MOTIFS (CpG-ODN) AND FORMULATION OF CpG WITH NANOPARTICLES TO ENHANCE ITS EFFICACY IN NEONATAL BROILER CHICKENS

  2018cites this paper
• Biomaterials for vaccine‐based cancer immunotherapy

  2018cites this paper
• Transitory Spontaneous Remission of Myelodysplasia in an Elderly Man while Receiving Intravesical Bacillus Calmette-Guérin for Bladder Cancer: A Case Report and Review of the Literature

  2018cites this paper
• Plazmidy jako wektory do terapii genowej

  2017cites this paper
• Pathogen‐associated Molecular Patterns

  2017cites this paper
• Allergy Immunity Regulation and Synergism of Bifidobacteria

  2017cites this paper
• Cytokine-CpG Motif Oligodeoxynucleotide Co-inoculation in the Murine Malaria Model

  2017cites this paper
• CpG-oligodeoxynucleotides developed for grouper toll-like receptor (TLR) 21s effectively activate mouse and human TLR9s mediated immune responses

  2017cites this paper
• Microparticles and Nanoparticles for Cancer-Targeting Vaccines

  2017cites this paper
• Investigations on the molecular mode of action of the novel immunostimulator ZelNate: Activation of the cGAS-STING pathway in mammalian cells.

  2017cites this paper
• Mycobacteria-Derived Agents for the Treatment of Urological and Renal Cancers

  2017cites this paper
• Therapeutic Effect of Hydatid Cyst Liquid on Melanoma Tumor Growth in Mouse Model

  2016cites this paper
• Toll-Like Receptors, Systemic Lupus Erythematosus

  2016cites this paper
• Effects of phosphodiester and phosphorothioate ODN2216 on leukotriene synthesis in human neutrophils and neutrophil apoptosis.

  2016cites this paper
• Allergen Immunotherapy: Vaccine Modification.

  2016cites this paper
• Attenuated Salmonella sp. as a DNA Delivery System for Trypanosoma cruzi Antigens.

  2016cites this paper
• Systemic delivery of chTNT-3/CpG immunoconjugates for immunotherapy in murine solid tumor models

  2016cites this paper
• Oligonucleotide Therapies: The Past and the Present

  2015cites this paper
• New developments in oral vaccines and mucosal adjuvants.

  2015cites this paper
• Glioma

  2015cites this paper
• Effective CpG DNA delivery using amphiphilic cycloamylose nanogels.

  2015cites this paper
• Extramedullary Hematopoiesis (EMH) in Laboratory Animals: Offering an Insight into Stem Cell Research

  2015cites this paper
• Immunité et protection induites par un lentivecteur ADN innovant chez les modèles animaux de vaccination VIH-1.

  2015cites this paper
• CpG oligodeoxynucleotides as mucosal adjuvants

  2015cites this paper
• Spezifische Immuntherapie COB kranker Pferde mittels inhalativer Verabreichung einer nanopartikulär gebundenen CpG-ODN Sequenz in Kombination mit definierten Allergenen

  2015cites this paper
• Up-regulation of Toll-like Receptor 9 in Osteosarcoma.

  2015cites this paper
• CpG Oligodeoxynucleotide Inhibits Cockroach-Induced Asthma via Induction of IFN-γ+ Th1 Cells or Foxp3+ Regulatory T Cells in the Lung

  2015influential citation
• Polyarginine induces an antitumor immune response through binding to toll-like receptor 4.

  2014cites this paper
• Probiotical Cell Fragments (PCFs) as "Novel Nutraceutical Ingredients"

  2014cites this paper
• Route to Discovering the Immunogenic Properties of DNA from TLR9 to Cytosolic DNA Sensors

  2014cites this paper
• Bacterial Infections and the DNA Sensing Pathway

  2014cites this paper
• Innate immune sensing of nucleic acids from mycobacteria.

  2014cites this paper
• Die Interaktion der plasmazytoiden dendritischen Zelle mit dem CD8+ T-Lymphozyten

  2014cites this paper
• FC-98 Regulates TLR9-Mediated of CXCL-10 Expression in Dendritic Cells via MAPK and STAT1 Signaling Pathway

  2014cites this paper
• Innate Immune Signaling By, Genetic Adjuvants For, Dna Vaccination

  2013cites this paper
• The role of toll-like receptor 9 on B-cell activating factor expression and function in normal human B-cells

  2013cites this paper
• Role of Extrachromosomal Histone H2B on Recognition of DNA Viruses and Cell Damage

  2013cites this paper
• Innate Immune Signaling by, and Genetic Adjuvants for DNA Vaccination

  2013cites this paper
• Epithelial toll-like receptor 9 signaling in colorectal inflammation and cancer: clinico-pathogenic aspects.

  2013cites this paper
• Immunotherapeutic potential of CpG oligodeoxynucleotides in veterinary species

  2013cites this paper
• [Multilevel maturation of Toll-like receptor 9].

  2013cites this paper
• Wieloetapowy proces dojrzewania receptora Toll-podobnego 9* Multilevel maturation of Toll-like receptor 9

  2013cites this paper
• Toll-like receptor 9 and 21 have different ligand recognition profiles and cooperatively mediate activity of CpG-oligodeoxynucleotides in zebrafish

  2013cites this paper
• Viral vaccines for bony fish: past, present and future

  2013cites this paper
• Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system

  2012cites this paper
• Cytosolic Double-Stranded DNA as a Damage-Associated Molecular Pattern Induces the Inflammatory Response in Rat Pancreatic Stellate Cells: A Plausible Mechanism for Tissue Injury-Associated Pancreatitis

  2012cites this paper
• Induction of type I IFNs by intracellular DNA‐sensing pathways

  2012cites this paper
• [Analysis of the application of host innate immune response to control and prevent infection].

  2012cites this paper
• Die Rolle von zytosolischer DNA in der Pathogenese des Diabetes mellitus Typ 1

  2012cites this paper
• CpG DNA in the Prevention and Treatment of Infections

  2012cites this paper
• 3′poly-G-Tailed ODNs Inhibit F-spondin to Induce Cell Death and Neurite Retraction in Rat Embryonic Neurons

  2012cites this paper
• Therapeutic Applications of Synthetic CpG Oligodeoxynucleotides as TLR9 Agonists for Immune Modulation

  2012cites this paper
• CpG Oligodeoxynucleotides as TLR9 Agonists

  2012cites this paper
• The role of immunostimulatory nucleic acids in septic shock.

  2012cites this paper
• Immunotherapeutic approach with oligodeoxynucleotides containing CpG motifs (CpG-ODN) in malignant glioma.

  2012cites this paper
• DNA-basierte Immuntherapie gegen Krebs

  2012cites this paper
• Adjuvants and delivery systems in veterinary vaccinology: current state and future developments

  2011cites this paper
• Production of antibodies with peptide-CpG-DNA-liposome complex without carriers

  2011cites this paper
• Modulation of Endosomal Toll-Like Receptor-Mediated Immune Responses by Synthetic Oligonucleotides

  2011cites this paper
• Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens

  2011cites this paper
• Intratumoral Administration of Secondary Lymphoid Chemokine and Unmethylated Cytosine-phosphorothioate-guanine Oligodeoxynucleotide Synergistically Inhibits Tumor Growth in Vivo

  2011cites this paper
• Toll-Like Receptors in SLE

  2011cites this paper
• A more efficient killing machine : how CpG-oligodeoxynucleotides enhance natural killer cell cytokine production and cytotoxicity against leukemia initiating cells

  2011cites this paper
• TLR9 activation is important for the maintenance of mycobacteria-elicited pulmonary granulomatous responses, hallmarks of protective immune responses following mycobacterial infection. However, the mechanism or mechanisms underlying this effect of TLR9 are not clear. Here, we show that Tlr9-deficien

  2011cites this paper
• Induction of Th1 immune responses to Japanese cedar pollen allergen (Cry j 1) in mice immunized with Cry j 1 conjugated with CpG oligodeoxynucleotide.

  2011cites this paper
• Pivotal Role of ADP-ribosylation Factor 6 in Toll-like Receptor 9-mediated Immune Signaling*

  2011cites this paper
• Nucleic Acid Sensing by the Immune System: Roles For the Receptor For Advanced Glycation End Products (RAGE) and Intracellular Receptor Proteins: A Dissertation

  2011cites this paper